Degarelix CAS NO 214766-78-6 is a useful medicine to anti prostate cancer. It always called gonadotropin-releasing hormone (GnRH) receptor antagonists. We can provide high quality Degarelix CAS 214766-78-6. Degarelix is known for high purity, safe formulation and reliable. Degarelix works by decreasing the amount of testosterone (a male hormone) produced by the body. It can slow or stop the spread of prostate cancer cells. Degarelix always be injected under the skin in the stomach area, away from the ribs and waistline. It is better to injected once every 28 days by doctor. Our specification is sterile and pharmaceutical grade.

Thera. Category: Anti-cancer

Cas No.: 214766-78-6

Synonym: DEGARELIX;Degarelix acetate;N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-4-[2,6-dioxohexahydropyrimidin-4(S)-ylcarboxamido]-L-phenylalanyl-4-ureido-D-phenylalanyl-L-leucyl-N6-isopropyl-L-lysyl-L-prolyl-D-alaninamide acetate;D-Alaninamide, N-acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-((((4S)-2,6-dioxohexahydropyrimidin-4-yl)carbonyl)amino)-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-;Degarelix acetate(FE-200486,Degarelix);FirMagon

Molecular Formula: C82H103ClN18O16

Molecular Weight: 1632.28

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Advanced hormone-dependent prostate carcinoma